Steve Wigginton, CEO, Valence Health at Evolent Health, Inc. (EVH), sold 6,000 shares at $20.11 ($121K) on 2017-03-01, disclosed to the SEC on 2017-03-03.
Open-market sale of $121k EVH by CEO, Valence Health. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EVH | SELL | 2017-06-08 | $25K | — | Filing → |
| EVH | SELL | 2017-06-05 | $145K | — | Filing → |
| EVH | SELL | 2017-05-23 | $331K | — | Filing → |